<DOC>
	<DOCNO>NCT02765256</DOCNO>
	<brief_summary>To determine effect novel gut microbiota-targeted therapeutic regimen ( bowel lavage antibiotic without antifungal ) management active Crohn 's Disease ( CD ) refractory conventional , immunosuppressive therapy .</brief_summary>
	<brief_title>Fundamental Modification Gut Microbiota Treatment Refractory Crohn 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Fluconazole</mesh_term>
	<mesh_term>Ciprofloxacin</mesh_term>
	<mesh_term>Vancomycin</mesh_term>
	<mesh_term>Neomycin</mesh_term>
	<mesh_term>Promethazine</mesh_term>
	<mesh_term>Diphenhydramine</mesh_term>
	<mesh_term>Polyethylene glycol 3350</mesh_term>
	<criteria>Participant capable give informed consent Males females 1864 year age Normal kidney function ( define normal serum creatinine [ male : &lt; 1.27 mg/dL ; female : &lt; 1.03 mg/dL ] ) Normal aspartate aminotransferase [ AST ] ( &lt; 41 U/L ) , alanine aminotransferase [ ALT ] ( &lt; 63 U/L ) , alkaline phosphatase ( &lt; 126 U/L ) Active CD define HBI ≥ 8 CRP &gt; 5 mg/dL hsCRP &gt; 10mg/L ( 1mg/dL ) fecal calprotectin ( FCP ) &gt; 400 mcg/g ( within one month enrollment ) Have treat one follow therapies** least 8 week primary nonresponse initial response , follow loss response [ LOR ] ( selfreported worsening symptom ≥ 7 day ) : azathioprine , 6mercaptopurine , methotrexate , adalimumab , certolizumab , golimumab , infliximab , natalizumab , vedolizumab **These medication must administer standard , therapeutic dosage . Known suspect stricturing disease produce obstructive symptom Active Clostridium difficile infection Unwillingness provide inform consent Allergy intolerance medication use study History kidney disease History liver disease Pregnant lactating female Baseline QTc interval EKG &gt; 430 male &gt; 450 female Participants , opinion investigator , may noncompliant study schedule procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>